# The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients

> **NCT01526876** · PHASE4 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** clevidipine butyrate

## Key facts

- **NCT ID:** NCT01526876
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-12-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated by Sponsor
- **Last updated:** 2017-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526876, "The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01526876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*